spacer
home > pmps > spring 2019 > automation: the definition of common sense
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Automation: The Definition of Common Sense

Companies’ continued reliance on manual processes and disparate labelling systems often culminates in pricey product recalls. In 2018, the return of over a million units and 9% of all medical device recall events were due to labelling issues. Organisations are known to spend as much as US $350,000 for every global label change. However, despite opportunities to de-risk the process through automated technologies, many persist with archaic methodologies that leave them vulnerable to human error. This absurdity is as unsustainable as it is avoidable.

As global regulations stiffen and the cost of noncompliance climbs, manufacturers must find a method to end the madness. Those who do will not only remove risk from their business, they will unlock the potential for additional cost savings that could transform the bottom line.

Labelling errors are a recurring reality for medical devices. The scale of the problem has barely shifted since 2012 when, just like now, around 10% of product recalls were label related. However, as label content becomes more complex with the introduction of new regulations, this figure will only increase if companies do not proactively review and strengthen their labelling infrastructure. The telltale signs of suboptimal operations are evident in the most prevalent causes of labelling recalls.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Craig Jones has the responsibility of understanding customer needs and industry challenges to drive solutions to improve efficiency, minimise risk, address regulatory requirements, and provide new approaches to business systems and processes. Craig has 15 years’ experience delivering validated label lifecycle management solutions to life science and healthcare industries, including medical device, pharma, and clinical trial organisations. His experience includes roles as an industry consultant, in IT management, and as a senior manager for global technical support and professional services.
spacer
Craig Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Regulatory bottlenecks mean EU clinicians and patients could lose access to medical devices under new rules

European clinicians and their patients could lose access to vital medical devices, including in-vitro diagnostics, due to a lack of agencies able to certify products in time to comply with strict new regulations.
More info >>

White Papers

Cleaning Validation: What do you need to consider to ensure a successful outcome?

RSSL

Cross contamination must be avoided in the Pharmaceutical industry at all costs and successful cleaning validation ensures that patients are not put at risk due to cross contamination. The process can be divided into a number of sections each of which must be fully understood and areas of concern addressed to ensure a successful outcome across the entire process. This spans both the manufacturing and subsequent analytical and microbological support. The data used to confirm a positive/successful cleaning validation is underpinned by the results of validated analytical methods. It is essential that these results are truly representative as patient safety is based upon the absence of equipment residues. So what are those areas of concern, what affects your ability to get a successful outcome and what do you need to consider when carrying out a Cleaning Validation exercise?
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement